Cardiac resynchronization therapy (CRT) is an established treatment option for adult patients suffering heart failure due to idiopathic or ischemic cardiomyopathy associated with electromechanical dyssynchrony. There is limited evidence suggesting similar efficacy of CRT in patients with congenital heart disease (CHD). Due to the heterogeneity of structural and functional substrates, CRT implantation techniques are different with a thoracotomy or hybrid approach prevailing. Efficacy of CRT in CHD seems to depend on the anatomy of the systemic ventricle with best results achieved in systemic left ventricular patients upgraded to CRT from conventional pacing. Indications for CRT in patients with CHD were recently summarized in the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease and are presented in the text.

• Klíčová slova
• Biventricular pacemakers, artificial, Cardiomyopathy, Dyssynchrony, Heart failure, Prognosis,
• MeSH
• dospělí MeSH
• dysfunkce levé srdeční komory komplikace   diagnóza   prevence a kontrola   MeSH
• lidé MeSH
• medicína založená na důkazech MeSH
• srdeční resynchronizační terapie metody   MeSH
• srdeční selhání komplikace   diagnóza   prevence a kontrola   MeSH
• vrozené srdeční vady komplikace   diagnóza   terapie   MeSH
• výsledek terapie MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• přehledy MeSH